REQUEST A DEMO
Total
USD $0.00
Search more companies

Incheon Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Incheon Pharmaceutical Co.,Ltd. Profile Updated: October 27, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Incheon Pharmaceutical Co.,Ltd. is an enterprise in South Korea, with the main office in Incheon. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on March 21, 1997. It currently has a total number of 285 (2023) employees. From the latest financial highlights, Incheon Pharmaceutical Co.,Ltd. reported a net sales revenue increase of 22.72% in 2022. Its total assets grew by 18.24% over the same period. Incheon Pharmaceutical Co.,Ltd.’s net profit margin increased by 0.43% in 2022.

Headquarters
85-2, Ilsin-ro Bupyeong-gu Incheon
Incheon; Incheon;

Contact Details: Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.

Website: http://inchunpharm.com

Basic Information
Total Employees:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Incheon Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
March 21, 1997
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
23.2%
Purchase this report to view the information.
22.9%
Purchase this report to view the information.
21.9%
Subsidiaries
Sg-Medipharm.Com
Company Performance
Financial values in the chart are available after Incheon Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
22.72%
Total operating revenue
22.72%
Operating profit (EBIT)
50.14%
EBITDA
46.57%
Net Profit (Loss) for the Period
103.83%
Total assets
18.24%
Total equity
16.24%
Operating Profit Margin (ROS)
0.26%
Net Profit Margin
0.43%
Return on Equity (ROE)
6.7%
Debt to Equity Ratio
-2.8%
Quick Ratio
0.07%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?